{"disease":{"id":"heart-conditions","name":"heart conditions"},"drugs":{"marketed":[{"drug_id":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","indication_name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants with a high risk of RSV disease due to certain heart conditions.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Respiratory Syncytial Virus Prefusion F Subunit Vaccine","generic_name":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Respiratory Syncytial Virus (RSV)","drug_class":"Vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"prevenar-20","indication_name":"Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, and 23F in adults 18 years of age and older with heart conditions","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prevenar 20","generic_name":"prevenar-20","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"prevenar-20","indication_name":"Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, and 23F in adults 50 years of age and older with heart conditions","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prevenar 20","generic_name":"prevenar-20","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"prevenar-20","indication_name":"Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, and 23F in adults 65 years of age and older with heart conditions","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prevenar 20","generic_name":"prevenar-20","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":55,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04706481","title":"Archival of Human Biological Samples in CU-Med Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06527703","title":"An International Prospective, Observational, Multi-centre Study on the Duration of Pre-operative Liquid Fasting","phase":"","overall_status":"COMPLETED","enrollment_count":5100,"lead_sponsor_name":"Mater Dei Hospital, Malta","has_results":false},{"nct_id":"NCT04065620","title":"Ambulatory Blood Pressure in HFPEF Outcomes Global Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Hospital Clinic of Barcelona","has_results":false},{"nct_id":"NCT07477197","title":"Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT05185232","title":"Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Children's National Research Institute","has_results":false},{"nct_id":"NCT07094737","title":"The Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P) Registry: An Observational Study on Cardiac Rehabilitation in Patients With Coronary Disease or Heart Failure","phase":"","overall_status":"RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Fondazione Don Carlo Gnocchi Onlus","has_results":false},{"nct_id":"NCT06831994","title":"Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity","phase":"NA","overall_status":"RECRUITING","enrollment_count":660,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT06681584","title":"Comparison of the Diagnostic Performance and Costs of FFRB Vs. Standard Care in Suspected Coronary Artery Disease.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":340,"lead_sponsor_name":"National Heart Centre Singapore","has_results":false},{"nct_id":"NCT04766125","title":"Psychological Factors in Cardiac Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT05393362","title":"Effectiveness of a Cardiac Rehabilitation Program in Elderly Patients With Heart Failure.","phase":"NA","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"University of Malaga","has_results":false},{"nct_id":"NCT04515758","title":"Determining the Feasibility of Implementing a Combined Cognitive and Exercise Training Program for Older Adults in a Community Setting.","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"University of Waterloo","has_results":false},{"nct_id":"NCT04452201","title":"Parent Communication for Feeding an Infant With a Heart Defect","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT05518136","title":"Evaluations of Cardiopulmonary Function and Motor Development of Congenital Heart Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Gejingwa Zhao","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}